Evidence map›Paper›PMID 38633712›Full record

ArticleInfectious diseases & clinical microbiology2022

Analysis of the Prophylactic use of Hydroxychloroquine at the Beginning of the COVID-19 Pandemic Among Physicians.

Mehmet Gökhan Gönenli, İlker Kayı, Nilüfer Alpay-Kanıtez, Tuba Baydaş, Murat Köse, Emine Ayça Nalbantoğlu, Miraç Vural Keskinler, Timur Selçuk Akpınar, Önder Ergönül

Open access · hybridAbstract read
In one paragraph

Article in Infectious diseases & clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Mehmet Gökhan GönenliDepartment of Internal Medicine, Koç University Hospital, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-2925-7048
İlker KayıDepartment of Public Health, Koç University Hospital, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-4115-6613
Nilüfer Alpay-KanıtezDepartment of Internal Medicine, Koç University Hospital, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-1185-5816
Tuba BaydaşDepartment of Internal Medicine, Bezmialem University Hospital, İstanbul, Turkey.ORCID https://orcid.org/0000-0001-7336-4647
Murat KöseDepartment of Internal Medicine, İstanbul University İstanbul School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-7487-9287
Emine Ayça NalbantoğluDepartment of Internal Medicine, Koç University Hospital, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-7405-0591
Miraç Vural KeskinlerDepartment of Internal Medicine, Istanbul Medeniyet University, Göztepe Education and Research Hospital, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-4863-9666
Timur Selçuk AkpınarDepartment of Internal Medicine, İstanbul University İstanbul School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-9591-4475
Önder ErgönülDepartment of Infectious Diseases and Clinical Microbiology, Koç University School of Medicine, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-1935-9235
Koç University · TRIstanbul University · TRBezmiâlem Vakıf Üniversitesi · TRIstanbul Medeniyet University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Throughout the pandemic, physicians working at the frontlines have embarked on various quests to protect themselves, and many physicians preferred using hydroxychloroquine (HQN) as a prophylactic agent. This study aimed to investigate the reasons leading physicians to use HQN and its effects on them. Materials and Methods: This study is cross-sectional with a target population of physicians working in pandemic hospitals in İstanbul, Turkey. We invited participants from seven hospitals via email between May 14 and June 13, 2020. An online questionnaire, including 57 questions, was sent to physicians. Results: A total of 148 (26%) physicians out of 564 participants had used hydroxychloroquine for prevention. Older physicians and those with a history of exposure to COVID-19 patients without protection used prophylactic HQN more frequently. The use of HQN did not differ statistically in terms of being infected among the exposed physicians ( Conclusion: Prophylactic HQN use was more common among physicians older than 40 years and with higher exposure rates to a COVID-19 patient without protection. The physicians working on the front line had the highest rate of infection. HQN was not effective in the prophylaxis of COVID-19 among the exposed physicians.

Indexed as

COVID-19hydroxychloroquinephysiciansprophylaxis

Identifiers

PMID38633712
PMCPMC10986685
OpenAlexW4316040217

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.